Cardiff Oncology Inc (CRDF)

Apr 03, 2025

Lucid Capital Markets sets $14 target on Cardiff Oncology stock By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 03, 2025

Cardiff Oncology Inc (CRDF) Has A Gold Mine On Its Hands - stocksregister.com

Apr 03, 2025

Apr 01, 2025

Charles Schwab Investment Management Inc. Sells 19,629 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Apr 01, 2025

Mar 26, 2025

Is Cardiff Oncology, Inc. (CRDF) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025

Mar 24, 2025

Bank of New York Mellon Corp Increases Stock Holdings in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Mar 24, 2025

Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025

Mar 12, 2025

Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze? - Mugglehead

Mar 12, 2025

Mar 10, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: Wha - GuruFocus.com

Mar 10, 2025

Mar 10, 2025

Future Industry Growth Of Metastatic Prostate Cancer Market - openPR

Mar 10, 2025

Mar 10, 2025

Rhumbline Advisers Buys 10,290 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Mar 10, 2025

Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025

Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - Canada NewsWire

Mar 08, 2025

Mar 05, 2025

Cardiff Oncology’s Earnings Call: Optimism Amid Challenges - MSN

Mar 05, 2025

Mar 05, 2025

Financial Review: Kymera Therapeutics (NASDAQ:KYMR) vs. Cardiff Oncology (NASDAQ:CRDF) - Defense World

Mar 05, 2025

Mar 04, 2025

All You Need to Know About Cardiff Oncology (CRDF) Rating Upgrade to Buy - Nasdaq

Mar 04, 2025

Mar 03, 2025

Q1 Earnings Forecast for CRDF Issued By William Blair - Defense World

Mar 03, 2025

Mar 03, 2025

Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $17.00 - Defense World

Mar 03, 2025

Mar 01, 2025

HC Wainwright Forecasts Strong Price Appreciation for Cardiff Oncology (NASDAQ:CRDF) Stock - MarketBeat

Mar 01, 2025

Mar 01, 2025

Cardiff Oncology Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 01, 2025

Feb 28, 2025

Cardiff Oncology (NASDAQ:CRDF) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Feb 28, 2025

Cardiff Oncology plans mixed shelf offering - MSN

Feb 28, 2025

Feb 28, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Call Highlights: Financial Fortification and ... - Yahoo Finance

Feb 28, 2025

Feb 27, 2025

Cardiff Oncology Highlights Progress in Cancer Trials - TipRanks

Feb 27, 2025

Feb 27, 2025

Cardiff Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

Earnings call transcript: Cardiff Oncology Q4 2024 highlights strategic advances - Investing.com

Feb 27, 2025

Feb 27, 2025

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - The Manila Times

Feb 27, 2025

Feb 27, 2025

Cardiff Oncology Reports Positive Initial Efficacy Data for Onvansertib in Metastatic Colorectal Cancer and Secures $40 Million Financing - Nasdaq

Feb 27, 2025

Feb 27, 2025

Cardiff Oncology, Inc. SEC 10-K Report - TradingView

Feb 27, 2025

Feb 26, 2025

Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 26, 2025

Feb 25, 2025

Cardiff Oncology Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Feb 25, 2025

Feb 25, 2025

Cardiff Oncology to Present at Upcoming Investor Conferences - The Manila Times

Feb 25, 2025

Feb 24, 2025

Can Cardiff Oncology's New Colorectal Cancer Approach Transform Treatment? CEO to Reveal Strategy - StockTitan

Feb 24, 2025

Feb 23, 2025

Critical Contrast: Cardiff Oncology (NASDAQ:CRDF) versus Vir Biotechnology (NASDAQ:VIR) - Defense World

Feb 23, 2025

Feb 22, 2025

Cardiff Oncology (CRDF) to Release Earnings on Thursday - Defense World

Feb 22, 2025

Feb 22, 2025

Cardiff Oncology (CRDF) Projected to Post Earnings on Thursday - MarketBeat

Feb 22, 2025

Feb 20, 2025

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update - The Manila Times

Feb 20, 2025

Feb 20, 2025

Can Cardiff Oncology's Q4 Earnings Reveal New Cancer Drug Progress? - StockTitan

Feb 20, 2025

Feb 20, 2025

Bullish Cardiff Oncology Insiders Rewarded As Their Investment Rises To US$1.81m - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Growth in Short Interest - MarketBeat

Feb 19, 2025

Feb 19, 2025

Taking on analysts’ expectations and winning: Cardiff Oncology Inc (CRDF) - SETE News

Feb 19, 2025

Feb 18, 2025

Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib (NASDAQ:CRDF) - Seeking Alpha

Feb 18, 2025

Feb 18, 2025

Cardiff Oncology, Inc. (NASDAQ:CRDF) Sees Significant Increase in Short Interest - Defense World

Feb 18, 2025

Feb 14, 2025

SG Americas Securities LLC Sells 6,103 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Feb 14, 2025